STREAMING NOW: Watch Now

Johnson & Johnson asks FDA to authorize its Covid-19 vaccine

Johnson & Johnson...

Posted: Feb 5, 2021 1:49 AM
Updated: Feb 5, 2021 9:45 PM

Johnson & Johnson officially asked the US Food and Drug Administration for an emergency use authorization of its Covid-19 vaccine Thursday, taking forward the possibility of a third coronavirus vaccine for the US market.

'Today's submission for Emergency Use Authorization of our investigational single-shot COVID-19 vaccine is a pivotal step toward reducing the burden of disease for people globally and putting an end to the pandemic,' Dr. Paul Stoffels, Chief Scientific Officer at Johnson & Johnson, said in a statement.

The FDA has scheduled a public meeting of its Vaccines and Related Biological Products Advisory Committee for Feb. 26. The independent group of experts will look at the data and make a recommendation that the agency takes into consideration when it makes a decision.

This means an EUA will not come before the end of the month, if the FDA decides to grant one. But adding a third vaccine to the mix would add both supply and flexibility to the struggling US efforts to vaccinate the population.

If the FDA decides to authorize the vaccine, the US Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices will meet to discuss whether the vaccine should be given to Americans and if so, who should get it first.

This same regulatory process for Pfizer took a little over three weeks. For Moderna it was a little more than two.

The Johnson & Johnson vaccine is a little different than the two authorized Covid-19 vaccines. The vaccine, made through a collaboration of J&J's vaccine division, Janssen Pharmaceutical, and Beth Israel Deaconess Medical Center in Boston, is delivered in a single shot. Pfizer and Moderna's require two.

Janssen's is considered versatile since it is considered stable for up to three months kept in regular refrigerated temperatures and doesn't need the deep freeze like Pfizer's.

Johnson & Johnson's Covid-19 vaccine was shown to be 66% effective in preventing moderate and severe disease in a global Phase 3 trial, according to the company. The vaccine is 85% effective overall at preventing hospitalization and 100% at preventing death in all regions where it was tested.

Its efficacy against moderate and severe disease ranged from one country to another: 72% in the US, 66% in Latin America and 57% in South Africa. This was measured starting one month after the shot.

In the South African arm of the clinical trial, the majority of the cases were due to a variant known as B.1.351, which is more transmissible and which carries mutations that make it less susceptible to the antibody immune response -- including antibodies that would be prompted by vaccination. People who did get a moderate case of Covid-19 in the trial tended to develop a milder course of the disease with fewer symptoms, according to the company.

The J&J vaccine works a little differently than the Moderna and Pfizer vaccines. Those two use messenger RNA, genetic instructions delivered in a fat droplet that prompt the body to make what looks like a piece of the virus. With the J&J vaccine the genetic material is delivered in a a common cold virus called an adenovirus, which has been disabled so it doesn't replicate itself or make people sick.

The US government has ordered 100 million doses and J&J says it can meet this commitment by June. 'Upon authorization of our investigational COVID-19 vaccine for emergency use, we are ready to begin shipping,' Stoffels said.

Oregon Coronavirus Cases

Data is updated nightly.

Cases: 361240

Reported Deaths: 4318
CountyCasesDeaths
Multnomah56287712
Washington39109325
Marion37168457
Clackamas30096309
Lane28087306
Jackson23248310
Deschutes20680125
Umatilla14567151
Linn13113132
Douglas12237251
Josephine9451198
Yamhill8820114
Klamath8146122
Polk746481
Malheur568578
Benton559831
Coos510295
Columbia388144
Jefferson381254
Lincoln324139
Union321550
Crook296346
Wasco291941
Clatsop244828
Baker204529
Tillamook198033
Hood River195837
Morrow186623
Curry182725
Harney114727
Grant100213
Lake96012
Wallowa69312
Gilliam1594
Sherman1573
Wheeler1091
Unassigned00

California Coronavirus Cases

Data is updated nightly.

Cases: 4854041

Reported Deaths: 71417
CountyCasesDeaths
Los Angeles148510526549
Riverside3716705041
San Diego3678574183
San Bernardino3586775720
Orange3251235578
Sacramento1596362313
Kern1472941652
Fresno1463182094
Santa Clara1455431897
Alameda1206921415
San Joaquin1027761721
Ventura1010381167
Contra Costa1000181008
Stanislaus862991335
Tulare80375978
San Francisco54440649
San Mateo54168623
Monterey50911586
Solano46063341
Santa Barbara45223523
Merced42422581
Sonoma40997404
Placer39435429
Imperial36071766
Kings32938325
San Luis Obispo29973333
Madera23955285
Shasta23924352
Butte23818273
Santa Cruz21034221
Yolo20397248
Marin17706244
El Dorado17207149
Sutter13937175
Napa12898100
Yuba1011582
Tehama9534110
Humboldt9269109
Nevada916790
Mendocino766787
Lassen758747
San Benito744972
Tuolumne691790
Lake6631105
Amador547364
Siskiyou451246
Glenn438433
Calaveras391481
Del Norte358742
Colusa307618
Inyo214241
Mono16723
Plumas16607
Mariposa133916
Trinity88011
Modoc6895
Sierra1880
Unassigned1460
Alpine1050
Out of CA00
Medford
Cloudy
53° wxIcon
Hi: 63° Lo: 44°
Feels Like: 53°
Brookings
Cloudy
54° wxIcon
Hi: 60° Lo: 48°
Feels Like: 54°
Crater Lake
Cloudy
53° wxIcon
Hi: 42° Lo: 26°
Feels Like: 53°
Grants Pass
Cloudy
53° wxIcon
Hi: 67° Lo: 48°
Feels Like: 53°
Klamath Falls
Mostly Cloudy
49° wxIcon
Hi: 56° Lo: 36°
Feels Like: 42°
Lingering showers today
KDRV Radar
KDRV Fire Danger
KDRV Weather Cam

Community Events